Turn Therapeutics (TTRX) EPS (Weighted Average and Diluted) (2024 - 2026)
Turn Therapeutics' quarterly EPS (Weighted Average and Diluted) came in at -$0.03 in Q1 2026, down 200.0% year-on-year from $0.03 in Q1 2025, and down 400.0% quarter-over-quarter from $0.01 in Q4 2025.
Turn Therapeutics has reported EPS (Weighted Average and Diluted) for 3 years, with the latest figure at -$0.03 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) fell 200.0% year-over-year to -$0.03; the trailing twelve-month figure through Mar 2026 stood at -$0.1 (changed N/A YoY), and the FY2025 full-year result was -$0.12, down 71.43% from the prior year.
- EPS (Weighted Average and Diluted) for Q1 2026 stood at -$0.03, down from $0.01 in the prior quarter.
- The five-year high for EPS (Weighted Average and Diluted) was $0.01 in Q4 2025, with the low at -$0.07 in Q3 2025.
- Average EPS (Weighted Average and Diluted) over 3 years is -$0.02, with a median of -$0.02 recorded in 2024.
- Year-over-year, EPS (Weighted Average and Diluted) surged 150.0% in 2025 and sank 200.0% in 2026.
- Tracing TTRX's EPS (Weighted Average and Diluted) over 3 years: stood at -$0.02 in 2024, then surged by 150.0% to $0.01 in 2025, then slumped by 400.0% to -$0.03 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.03 (Q1 2026), $0.01 (Q4 2025), and -$0.07 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -4.43 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3,086.42 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 0.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 4.02 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 6.75 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.51 |
| 10 | Turn Therapeutics | 188.06 Mn | 188.06 Mn | - | -0.03 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.03 |
| Dec 31, 2025 | 0.01 |
| Sep 30, 2025 | -0.07 |
| Mar 31, 2025 | -0.01 |
| Dec 31, 2024 | -0.02 |
| Sep 30, 2024 | -0.03 |